PARP1 and cancer: PARP inhibitors bind to PARP, inhibiting PARylation, and also trap inactivated PARP in DNA, thereby blocking replication forks, which, in turn, leads to collapse and the generation of double-strand breaks in cancer cells [143,145,146].